Related Experiment Videos

Clinical and demographic evaluation of Behçet disease among different paediatric age groups

G K Sungur1, D Hazirolan, I Yalvac

  • 1Ankara Education and Research Hospital, 1st Ophthalmology Department, Ankara 06660, Turkey.

Insights

Pediatric Behçet disease (BD) shows age-dependent ocular manifestations. Younger children (<10 years) often present with anterior uveitis and a family history, while older children experience panuveitis. Early family screening is crucial for diagnosis and managing BD complications.

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Pediatrics

Background:

  • Behçet disease (BD) is a multisystemic inflammatory disorder.
  • Understanding pediatric BD is crucial for early diagnosis and management.
  • Ocular involvement is a significant manifestation of BD.

Purpose of the Study:

  • To describe the demographic and clinical features of Behçet disease in pediatric patients.
  • To identify age-specific ocular and extraocular findings in pediatric BD.
  • To investigate the role of gender and family history in the etiology of pediatric BD.

Main Methods:

  • A retrospective study of 62 pediatric patients diagnosed with BD.
  • Patients were categorized into three age groups: 0-10, 11-15, and 16-20 years.
  • Analysis of ocular and extraocular clinical findings, complications, and demographic data.

Main Results:

  • Gender did not significantly influence the etiology of BD.
  • In patients aged 0-10 years, a family history of BD was more common, and bilateral anterior uveitis was the primary ocular finding.
  • In patients aged 11-20 years, bilateral panuveitis with retinal vasculitis and retinitis were the most frequent ocular involvements.
  • Glaucoma, maculopathy, and cataract formation were the predominant complications.

Conclusions:

  • Age at presentation significantly impacts the type of ocular involvement in pediatric BD.
  • Anterior uveitis is more common in younger children (<10 years), whereas panuveitis is more prevalent in older children (>10 years).
  • A positive family history in younger children highlights the importance of family screening for early BD diagnosis and complication management.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...